The European Stroke Organisation Conference (ESOC) 2017 took place this week from 16-18 May in Prague, Czech Republic. The third day of ESOC saw some exciting late breaking clinical trials.
Universty of Oxford News Release:Immediate aspirin after mini-stroke substantially reduces risk of major stroke
Thousands of stroke survivors with visual problems could improve their sight from the comfort of their own home using two new web-based therapies.
We want to support the next generation of stroke research leaders to continue to improve stroke care and the lives of people affected by stroke in the years to come. We’re proud to introduce you to four researchers at the beginning of their careers who have recently been awarded Stroke Association research fellowships.
Made in collaboration with patients and staff, a goal-setting tool should be produced which is helpful to use on stroke rehabilitation units.
Intracerebral haemorrhage (ICH) is a type of stroke, which is caused by bleeding in the brain, ultimately leading to brain damage, disability and often death. We currently know very little about the biological changes that occur in the brain after intracerebral haemorrhage.
About 80% of strokes are caused by a blocked blood vessel. One third of these patients have a blockage of a large blood vessel in the neck or brain known as large artery occlusion stroke (LAOS).
Published in the journal Neuropsychologia, a new study sheds light on why some people with stroke have difficulty comprehending language.
This study will explore whether an existing therapy, Solution Focused Brief Therapy (SFBT), can be used for people with aphasia. Information will also be collected to design a future large-scale trial evaluating this approach.
Published in the journal Age and Ageing, a new systematic review of the current research suggests that anticoagulant drugs may have cognitive benefit for those with AF (atrial fibrillation).